Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S.L. Tiede, S.S. Pullamsetti, A. Sydykov, G. Lochnit, H. Tiede, H.A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, R.T. Schermuly (Bad Nauheim, Giessen, Germany). Screening for biomarkers in pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3165

Member's Comments

No comment yet.

Related content which might interest you: Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary hypertension: pathophysiology and diagnosis Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007 Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations Source: Eur Respir Rev 2013; 22: 515-525 Year: 2013 The diagnosis of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017 Year: 2017 Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Biological markers predictors of pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 560s Year: 2005 Diagnosing pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension Year: 2015 Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018 Year: 2018 Risk assessment in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 390-398 Year: 2016 Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017 Year: 2018 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Early detection and management of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 306-312 Year: 2012 Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 New potential diagnostic biomarkers for pulmonary hypertension Source: Eur Respir J 2015; 46: 1390-1396 Year: 2015